Glimepiride + Lobeglitazone Tablet
Glimepiride + Lobeglitazone Tablet
Glimepiride + Lobeglitazone — PCD Pharma Franchise, Wholesale Supply & Third Party Manufacturing
Form: Tablet
Class: Fixed-Dose Combination — Sulphonylurea antidiabetic + Thiazolidinedione antidiabetic
✓ Pan-India Monopoly PCD
✓ Available Now
Pricing, brochure & monopoly territory within 24 hrs.
Glimepiride + Lobeglitazone Tablet is manufactured and supplied by Trumac Healthcare, a WHO-GMP certified pharmaceutical company in India. This tablet is available for monopoly PCD pharma franchise, wholesale and distributor supply, and third party / contract manufacturing across all Indian states.
Therapeutic Indications
- Type 2 diabetes mellitus, with diet and exercise
- Combination therapy with metformin, glitazones or DPP-4 inhibitors
- Improving insulin sensitivity in insulin-resistant type 2 diabetes
Mechanism of Action
Glimepiride — Glimepiride binds sulphonylurea receptors on pancreatic beta cells, closing ATP-sensitive potassium channels and stimulating insulin release. It may also modestly improve insulin sensitivity in peripheral tissues.
Lobeglitazone — Lobeglitazone mainly activates the nuclear receptor PPAR-gamma in fat, muscle and liver cells. This improves insulin sensitivity, increases glucose uptake into tissues and reduces glucose output from the liver, lowering blood sugar.
Combining these ingredients in one tablet provides complementary action on the target condition and simplifies therapy compared with taking the components separately.
Dosage & Administration
- Dosage of Glimepiride + Lobeglitazone Tablet must be individualised by the treating physician according to the patient's age, body weight, indication, disease severity and renal or hepatic function.
- Refer to the approved prescribing information for exact dose, frequency, route and duration of therapy.
- Do not exceed the prescribed dose, and complete the full course as advised.
- Dose adjustment may be required in renal or hepatic impairment, in the elderly and in paediatric patients.
- To be dispensed only against a valid prescription from a registered medical practitioner.
Side Effects
- Hypoglycaemia (low blood sugar)
- Weight gain
- Nausea or abdominal discomfort
- Fluid retention and swelling (oedema)
- Low blood sugar when combined with sulfonylureas
Contraindications
- Known hypersensitivity to any component of the formulation
- Type 1 diabetes or diabetic ketoacidosis
- Severe renal or hepatic impairment
- Heart failure or a history of heart failure
Storage
Store below 30 °C in a dry place, protected from light and moisture. Keep in the original packaging until use. Keep out of reach of children. Dispense strictly on a registered medical practitioner's prescription.
PCD Pharma Franchise & Third Party Manufacturing — Glimepiride + Lobeglitazone Tablet
- ✓ WHO-GMP certified manufacturing — every batch QC released
- ✓ Monopoly PCD franchise rights at district or state level
- ✓ Third party / contract manufacturing under your own brand
- ✓ Wholesale and distributor supply against drug licence + GST
- ✓ Attractive net rates with healthy PTR / PTS margins
- ✓ Dispatch within 48 hours of payment realisation
Composition: Glimepiride + Lobeglitazone. It is a fixed-dose combination of sulphonylurea antidiabetic and thiazolidinedione antidiabetic, used for type 2 diabetes mellitus, with diet and exercise and improving insulin sensitivity in insulin-resistant type 2 diabetes. Trumac Healthcare supplies it with complete quality documentation — batch Certificate of Analysis, GMP certificate and statutory invoicing — to PCD franchise partners, stockists, wholesalers and hospital supply chains nationwide.
Glimepiride + Lobeglitazone Tablet brings together Glimepiride (sulphonylurea antidiabetic) and Lobeglitazone (thiazolidinedione antidiabetic) in a single fixed-dose formulation.
PCD franchise partners receive monopoly territory rights at district or state level, promotional support including visual aids and sample literature, competitive net rates with healthy PTR/PTS margins, and dispatch within 48 hours of payment realisation. Third party manufacturing of Glimepiride + Lobeglitazone Tablet under your own brand name is available subject to minimum order quantity and valid drug licence and GST documentation.
Frequently Asked Questions
Who manufactures Glimepiride + Lobeglitazone Tablet in India?
Trumac Healthcare is a WHO-GMP certified manufacturer and supplier of Glimepiride + Lobeglitazone Tablet in India. We supply pan-India to PCD franchise partners, wholesalers, distributors and hospital chains, with full QC documentation and batch Certificate of Analysis. Contact +91 90416 77932 for net rates and availability.
What is Glimepiride + Lobeglitazone Tablet used for?
Glimepiride + Lobeglitazone Tablet is used for type 2 diabetes mellitus, with diet and exercise; combination therapy with metformin, glitazones or DPP-4 inhibitors; improving insulin sensitivity in insulin-resistant type 2 diabetes. It should be used as advised by a registered medical practitioner.
Is Glimepiride + Lobeglitazone Tablet available for PCD pharma franchise on monopoly basis?
Yes. Glimepiride + Lobeglitazone Tablet is available for monopoly PCD (Propaganda Cum Distribution) pharma franchise across India, with monopoly rights granted at district or state level. Franchise partners receive promotional support, territory protection, competitive net rates with healthy PTR/PTS margins and dedicated backend support.
Do you offer Glimepiride + Lobeglitazone for third party or contract manufacturing?
Yes. Trumac Healthcare undertakes third party manufacturing and contract manufacturing of Glimepiride + Lobeglitazone Tablet under your own brand name, subject to minimum order quantity and valid drug licence and GST documentation. Custom pack sizes, carton design and artwork are supported.
Can Glimepiride + Lobeglitazone Tablet be supplied on wholesale or distributor basis?
Yes. Beyond PCD franchise, this product is supplied to wholesalers, stockists and distributors at wholesale rates against a valid drug licence and GST registration. Bulk and institutional supply is available on request.
What is the therapeutic class of Glimepiride + Lobeglitazone?
Glimepiride + Lobeglitazone is a fixed-dose combination of sulphonylurea antidiabetic and thiazolidinedione antidiabetic (therapeutic class: Fixed-Dose Combination — Sulphonylurea antidiabetic + Thiazolidinedione antidiabetic).
What documentation is provided with each supply?
Every batch ships with a Certificate of Analysis (COA), GMP certificate, drug licence copies and statutory invoice. We also support PCD partner documentation including monopoly agreement, rate contract and product list.
How quickly can an order be dispatched?
Routine PCD orders are dispatched within 48 hours of payment realisation, subject to stock availability and your distance from our depot. For monopoly partners we maintain buffer stock against forecasted monthly off-take.
Is a prescription required for Glimepiride + Lobeglitazone Tablet?
Yes. This is a prescription medicine and must be used strictly under the supervision of a registered medical practitioner. PCD franchise distribution is through licensed retail pharmacies and hospital supply chains only.
Ready to start your PCD franchise for Glimepiride + Lobeglitazone Tablet?